<SEC-DOCUMENT>0000950103-25-014238.txt : 20251104
<SEC-HEADER>0000950103-25-014238.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104144434
ACCESSION NUMBER:		0000950103-25-014238
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251448252

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251448253

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236925_424b2-us2526702d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">The information in this preliminary
    pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities
    and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus
    supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any
    state where the offer or sale is not permitted.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">SUBJECT TO COMPLETION, DATED NOVEMBER
    4, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%; padding-left: 4.2pt; font-size: 30pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 34%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"><B>November &nbsp;&nbsp;&nbsp;&nbsp;, 2025</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"><B>Medium-Term Senior Notes, Series
    N</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"><B>Pricing Supplement No. 2025-USNCH29268</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"><B>Filed Pursuant to Rule 424(b)(2)</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"><B>Registration Statement Nos. 333-270327
    and 333-270327-01</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: gray"></P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE40; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Autocallable Barrier Securities Linked to the EURO STOXX
50<SUP>&reg;</SUP> Index Due November 29, 2028</P>

<P STYLE="color: #59AE40; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 5.05pt"><FONT STYLE="font-size: 10pt; color: #59AE40">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. Unlike conventional debt securities, the securities do not pay interest, do not guarantee the repayment of
principal at maturity and are subject to potential automatic early redemption on the terms described below. Your return on the securities
will depend on the performance of the underlying specified below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 5.05pt"><FONT STYLE="font-size: 10pt; color: #59AE40">&squarf;</FONT></TD><TD>The securities offer the potential for automatic early redemption at a premium following the valuation date prior to the final valuation
date if the closing value of the underlying is greater than or equal to the initial underlying value. If the securities are not automatically
redeemed prior to maturity, the securities will no longer offer the opportunity to receive a premium, but instead, at maturity, will provide
for (i) the opportunity to participate in any appreciation of the underlying from the initial underlying value at the upside participation
rate specified below and (ii) contingent repayment of the stated principal amount at maturity if the underlying depreciates, <B>but only
</B>so long as the final underlying value is greater than or equal to the final barrier value specified below. <B>However, if the securities
are not automatically redeemed prior to maturity and the final underlying value is less than the final barrier value, you will lose 1%
of the stated principal amount of your securities for every 1% by which the final underlying value is less than the initial underlying
value. You may lose a significant portion, and up to all, of your investment.</B> Although you will have downside exposure to the underlying,
you will not receive dividends with respect to the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 4.5pt"><FONT STYLE="font-size: 10pt; color: #59AE40">&squarf;</FONT></TD><TD>In order to obtain the modified exposure to the underlying that the securities provide, investors must be willing to accept (i) an
investment that may have limited or no liquidity and (ii) the risk of not receiving any amount due under the securities if we and Citigroup
Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings
Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE40">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying: </B></FONT></TD>
    <TD COLSPAN="3" STYLE="layout-grid-mode: char"><FONT STYLE="font-size: 10pt">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Stated principal amount: </B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 24, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 28, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Valuation dates: </B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 24, 2026 and November 24, 2028 (the &ldquo;final valuation date&rdquo;), each subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Maturity date: </B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Unless earlier redeemed, November 29, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Automatic early redemption:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">If, on the valuation date prior to the final valuation date, the closing value of the underlying is greater than or equal to the initial underlying value, the securities will be automatically redeemed on the third business day immediately following that valuation date for an amount in cash per security equal to $1,000 <I>plus</I> the premium.&nbsp;&nbsp;If the securities are automatically redeemed following the valuation date prior to the final valuation date, they will cease to be outstanding and you will not have the opportunity to participate in any appreciation of the underlying.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Premium:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The premium applicable to the valuation date prior to the final valuation
    date is the percentage of the stated principal amount set forth below. <B>The premium may be significantly less than the appreciation
    of the underlying from the pricing date to the valuation date prior to the final valuation date.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>November 24, 2026: &#9;10.00% of the stated principal amount</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity, for each security you then hold, an amount in cash equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;
    </FONT>If the final underlying value is <B>greater than </B>the initial underlying value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt">$1,000 + the return amount</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;
    </FONT>If the final underlying value is <B>less than or equal to </B>the initial underlying value but <B>greater than or equal to</B>
    the final barrier value:<BR>
    $1,000</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;
    </FONT>If the final underlying value is <B>less than</B> the final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt; text-indent: -13.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt">$1,000 + ($1,000 &times; the underlying return)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.1pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value is less than the final barrier value, you will receive significantly less than the stated principal amount
    of your securities, and possibly nothing, at maturity.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="background-color: #EAF3E0">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Initial underlying value:</B></FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the closing value of the underlying on the pricing date</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underlying return:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">(i) The final underlying value <I>minus </I>the initial underlying value, <I>divided by</I> (ii) the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Final barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 70.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Return amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 &times; the underlying return &times; the upside participation rate</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Upside participation rate:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">At least 200.00%. The actual upside participation rate will be determined on the pricing date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">17331BYM5 / US17331BYM52</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;CGMI&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 30%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Issue price</B></FONT><B><FONT STYLE="font-size: 10pt; color: #59AE40"><SUP>(1)(2)</SUP></FONT></B></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Underwriting fee</B></FONT><B><FONT STYLE="font-size: 10pt; color: #59AE40"><SUP>(3)</SUP></FONT></B></TD>
    <TD STYLE="width: 27%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Proceeds to issuer<SUP>(4)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$975.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) Citigroup Global Markets Holdings Inc. currently expects that the
estimated value of the securities on the pricing date will be at least $912.00 per security, which will be less than the issue price.
The estimated value of the securities is based on CGMI&rsquo;s proprietary pricing models and our internal funding rate. It is not an
indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other
person may be willing to buy the securities from you at any time after issuance. See &ldquo;Valuation of the Securities&rdquo; in this
pricing supplement.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) The issue price for investors purchasing the securities in fee-based
advisory accounts will be $975.00 per security. See &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) CGMI will receive an underwriting fee of up to $25.00 for each security
sold in this offering. The total underwriting fee and proceeds to issuer in the table above give effect to the actual total underwriting
fee. For more information on the distribution of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.
In addition to the underwriting fee, CGMI and its affiliates may profit from expected hedging activity related to this offering, even
if the value of the securities declines. See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(4) The per security proceeds to issuer indicated above represent the
minimum per security proceeds to issuer for any security, assuming the maximum per security underwriting fee. As noted above, the underwriting
fee is variable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-5.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &quot;SEC&quot;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense. <I>You should read this pricing supplement together with the accompanying product
supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="color: #59AE43"><B>Product Supplement No. EA-02-10 dated March 7, 2023</B></FONT></A>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="color: #59AE43"><B>Underlying Supplement No. 11 dated March 7, 2023</B></FONT></A><BR>
<A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="color: #59AE43"><B>Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Additional Information</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the accompanying
product supplement contains important information about how the closing value of the underlying will be determined and about adjustments
that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events with respect
to the underlying. The accompanying underlying supplement contains information about the underlying that is not repeated in this pricing
supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus
together with this pricing supplement in deciding whether to invest in the securities. Certain terms used but not defined in this pricing
supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Hypothetical Payment Upon Automatic Early Redemption</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following table illustrates how the amount payable per security
upon automatic early redemption will be calculated if the closing value of the underlying on the valuation date prior to the final valuation
date is greater than or equal to the initial underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 47%"><B>If the closing value of the underlying on the valuation date below is greater than or equal to the initial underlying value. . .</B></TD>
    <TD STYLE="vertical-align: top; width: 53%"><B>. . . then you will receive the following payment per security upon automatic early redemption:</B></TD></TR>
  <TR>
    <TD STYLE="font-size: 12pt"><FONT STYLE="font-size: 10pt">November 24, 2026</FONT></TD>
    <TD>$1,000 + applicable premium = $1,000 + $100.00 = $1,100.00</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If, on the valuation date prior to the final valuation date, the
closing value of the underlying is less than the initial underlying value, you will not receive the premium indicated above following
that valuation date. In order to receive the premium indicated above, the closing value of the underlying on the valuation date prior
to the final valuation date must be greater than or equal to the initial underlying value.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Payment at Maturity Diagram</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram below illustrates the payment at maturity of the securities,
assuming the securities have not previously been automatically redeemed, for a range of hypothetical underlying returns. The diagram assumes
that the upside participation rate will be set at the lowest value indicated on the cover page of this pricing supplement. The actual
upside participation rate will be determined on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends with respect
to the underlying. The diagram and examples below do not show any effect of lost dividend yield over the term of the securities.</B> See
&ldquo;Summary Risk Factors&mdash;You will not receive dividends or have any other rights with respect to the underlying&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 100%; border: Black 1pt solid; text-align: center; font-size: 14pt; color: #296DC1"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>Payment at Maturity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.gif" ALT="" STYLE="height: 434px; width: 601px"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Wingdings; color: #59AE43">n</FONT>
    The Securities&#9;<FONT STYLE="font-family: Wingdings">n</FONT> The Underlying</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40"><FONT STYLE="font-weight: normal">Hypothetical Examples
of the Payment at Maturity</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate how to determine the payment at maturity
on the securities, assuming the securities are not automatically redeemed prior to maturity and assuming the various hypothetical final
underlying values indicated below. The examples are solely for illustrative purposes, do not show all possible outcomes and are not a
prediction of what the actual&nbsp;payment at maturity on the securities will be. The actual payment at maturity will depend on the actual
final underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on a hypothetical <FONT STYLE="background-color: white">initial
underlying value of 100 and a hypothetical final barrier value of 70 </FONT>and do not reflect the actual initial underlying value or
final barrier value. For the actual initial underlying value and final barrier value, see the cover page of this pricing supplement. We
have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding of how the securities
work. However, you should understand that the actual payment at maturity on the securities will be calculated based on the actual initial
underlying value and final barrier value, and not the hypothetical values indicated below. For ease of analysis, figures below have been
rounded. The examples below assume that the upside participation rate will be set at the lowest value indicated on the cover page of this
pricing supplement. The actual upside participation rate will be determined on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Example 1&mdash;Upside Scenario.</B>
The final underlying value is 110 (a 10.00% increase from the initial underlying value) , which is <B>greater than</B> the initial underlying
value.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Payment at maturity per security
= $1,000 + the return amount</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">= $1,000 + ($1,000 &times; the
underlying return &times; the upside participation rate)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">= $1,000 + ($1,000 &times; 10.00%
&times; 200.00%)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">= $1,000 + $200.00</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">= $1,200.00</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">In this scenario, the underlying
has appreciated from the initial underlying value to the final underlying value, and your total return at maturity would equal the underlying
return <I>multiplied by</I> the upside participation rate.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Par Scenario.</B> The final underlying value is 95
(a 5.00% decrease from the initial underlying value), which is <B>less than</B> the initial underlying value but <B>greater than</B> the
final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = <FONT STYLE="background-color: white">$1,000
</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has depreciated from the initial underlying
value to the final underlying value, but not below the final barrier value. Because the final underlying value is greater than the final
barrier value, you would be repaid the stated principal amount of $1,000 per security at maturity but would not receive any positive return
on your investment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Downside Scenario.</B> The final underlying value
is 30 (a 70.00% decrease from the initial underlying value), which is <B>less than</B> the final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the final underlying value is less than the final barrier value,
you would receive a payment at maturity per security that is less than the stated principal amount, calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + ($1,000 &times; the underlying
return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; -70.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + -$700.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying has depreciated from the initial underlying
value to the final underlying value and the final underlying value is less than the final barrier value. As a result, your total return
at maturity in this scenario would be negative and would reflect 1-to-1 exposure to the negative performance of the underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Summary Risk Factors</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with the underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value. If the final underlying value is less than the final
barrier value, you will lose 1% of the stated principal amount of the securities for every 1% by which the underlying has declined from
the initial underlying value. There is no minimum payment at maturity on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B> You should not invest in the securities if you seek current income during the term of the
securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting the term of the securities.</B> If the closing value of
the underlying on the valuation date prior to the final valuation date is greater than or equal to the initial underlying value, the securities
will be automatically redeemed. If the securities are automatically redeemed following the valuation date prior to the final valuation
date, they will cease to be outstanding and you will not have the opportunity to participate in any appreciation of the underlying. Moreover,
you may not be able to reinvest your funds in another investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>You will not receive dividends or have any other rights with respect to the underlying. </B>You will not receive any dividends
with respect to the underlying. This lost dividend yield may be significant over the term of the securities. The payment scenarios described
in this pricing supplement do not show any effect of such lost dividend yield over the term of the securities. In addition, you will not
have voting rights or any other rights with respect to the underlying or the stocks included in the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing values of the underlying solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing values of the underlying on or near the valuation dates.</B> Whether
the securities will be automatically redeemed prior to maturity will depend on the closing values of the underlying solely on the valuation
date prior to the final valuation date, regardless of the closing values of the underlying on other days during the term of the securities.
If the securities are not automatically redeemed prior to maturity, what you receive at maturity will depend solely on the closing value
of the underlying on the final valuation date, and not on any other day during the term of the securities. Because the performance of
the securities depends on the closing values of the underlying on a limited number of dates, the securities will be particularly sensitive
to volatility in the closing values of the underlying on or near the valuation dates. You should understand that the closing value of
the underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity. </B>The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date,
based on CGMI&rsquo;s proprietary pricing models and our internal funding rate, is less than the issue price</B>. The difference is attributable
to certain costs associated with selling, structuring and hedging the securities that are included in the issue price. These costs include
(i) any selling concessions or other fees paid in connection with the offering of the securities, (ii) hedging and other costs incurred
by us and our affiliates in connection with the offering of the securities and (iii) the expected profit (which may be more or less than
actual profit) to CGMI or other of our affiliates in connection with hedging our obligations under the securities. These costs adversely
affect the economic terms of the securities</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">because, if they were lower, the economic terms of the securities
would be more favorable to you. The economic terms of the securities are also likely to be adversely affected by the use of our internal
funding rate, rather than our secondary market rate, to price the securities. See &ldquo;The estimated value of the securities would be
lower if it were calculated based on our secondary market rate&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models. </B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the closing value of the underlying, the dividend
yield on the underlying and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an
underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to
be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities set
forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #296DC1; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><FONT STYLE="color: black"><B>The estimated value of the securities would be lower if it were calculated based on our secondary market
rate. </B>The estimated value of the securities included in this pricing supplement is calculated based on our internal funding rate,
which is the rate at which we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally
lower than our secondary market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of
any purchases of the securities from you in the secondary market. If the estimated value included in this pricing supplement were based
on our secondary market rate, rather than our internal funding rate, it would likely be lower. We determine our internal funding rate
based on factors such as the costs associated with the securities, which are generally higher than the costs associated with conventional
debt securities, and our liquidity needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #59AE40">&nbsp;&nbsp;
</FONT><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors. </B>The value of your securities
prior to maturity will fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying,
the dividend yield on the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness,
as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating to the Securities&mdash;Risk
Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based on many unpredictable factors&rdquo;
in the accompanying product supplement. Changes in the closing value of the underlying may not result in a comparable change in the value
of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly less than
the issue price.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid
price provided by CGMI, and the value that will be indicated on any brokerage account statements prepared by CGMI or its affiliates,
will reflect a temporary upward adjustment. </B>The amount of this temporary upward adjustment will steadily decline to zero over the
temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The EURO STOXX 50<SUP>&reg;</SUP> Index is subject to risks
associated with non-U.S. markets.</B> Investments linked to the value of non-U.S. stocks involve risks associated with the securities
markets in those countries, including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings
in companies in certain countries. Also, there is generally less publicly available information about companies in some of these jurisdictions
than about U.S. companies that are subject to the reporting requirements of the SEC. Further, non-U.S. companies are generally subject
to accounting, auditing and financial reporting standards and requirements and securities trading rules that are different from those
applicable to U.S. reporting companies. The prices of securities in foreign markets may be affected by political, economic, financial
and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency
exchange laws. Moreover, the economies in such countries may differ favorably or unfavorably from the economy of the United States in
such respects as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The performance of the EURO STOXX 50<SUP>&reg; </SUP>Index
will not be adjusted for changes in the exchange rate between the euro and the U.S. dollar. </B>The EURO STOXX 50<SUP>&reg;</SUP> Index
is composed of stocks traded in euro, the value of which may be subject to a high degree of fluctuation relative to the U.S. dollar.
However, the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index and the value of your securities will not be adjusted for exchange
rate fluctuations. If the euro appreciates relative to the U.S. dollar over the term of the securities, the performance of the EURO STOXX
50<SUP>&reg;</SUP> Index as measured for purposes of the securities will be less than it would have been if it offered exposure to that
appreciation in addition to the change in the prices of the stocks included in the EURO STOXX 50<SUP>&reg;</SUP> Index.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of
the underlying. </B>The fact that we are offering the securities does not mean that we believe that investing in an instrument linked
to the underlying is likely to achieve favorable returns. In fact, as we are part of a global financial institution, our affiliates may
have positions (including short positions) in the underlying or in instruments related to the underlying, and may publish research or
express opinions, that in each case are inconsistent with an investment linked to the underlying. These and other activities of our affiliates
may affect the closing value of the underlying in a way that negatively affects the value of and your return on the securities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The closing value of the underlying may be adversely affected
by our or our affiliates&rsquo; hedging and other trading activities.</B> We expect to hedge our obligations under the securities through
CGMI or other of our affiliates, who may take positions in the underlying or in financial instruments related to the underlying and may
adjust such positions during the term of the securities. Our affiliates also take positions in the underlying or in financial instruments
related to the underlying on a regular basis (taking long or short positions or both), for their accounts, for other accounts under their
management or to facilitate transactions on behalf of customers. These activities could affect the closing value of the underlying in
a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us or
our affiliates while the value of the securities declines.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are
adverse to yours as a result of our affiliates&rsquo; business activities.</B> Our affiliates engage in business activities with a wide
range of companies. These activities include extending loans, making and facilitating investments, underwriting securities offerings
and providing advisory services. These activities could involve or affect the underlying in a way that negatively affects the value of
and your return on the securities. They could also result in substantial returns for us or our affiliates while the value of the securities
declines. In addition, in the course of this business, we or our affiliates may acquire non-public information, which will not be disclosed
to you.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will
make important determinations with respect to the securities.</B>&nbsp; If certain events occur during the term of the securities, such
as market disruption events and other events with respect to the underlying, CGMI, as calculation agent, will be required to make discretionary
judgments that could significantly affect your return on the securities. In making these judgments, the calculation agent&rsquo;s interests
as an affiliate of ours could be adverse to your interests as a holder of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk
Factors Relating to All Securities&mdash;The calculation agent, which is an affiliate of ours, will make important determinations with
respect to the securities&rdquo; in the accompanying product supplement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>Changes that affect the underlying may affect the value of
your securities.</B> The sponsor of the underlying may at any time make methodological changes or other changes in the manner in which
it operates that could affect the value of the underlying. We are not affiliated with the underlying sponsor and, accordingly, we have
no control over any changes such sponsor may make. Such changes could adversely affect the performance of the underlying and the value
of and your return on the securities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; color: #59AE40">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the
securities are unclear. </B> There is no direct legal authority regarding the proper U.S. federal tax treatment of the securities, and
we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently, significant aspects of the
tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as prepaid
forward contracts. If the IRS were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership
and disposition of the securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS
guidance could adversely affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">If you are a non-U.S. investor, you should review the discussion
of withholding tax issues in &ldquo;United States Federal Tax Considerations&mdash;Non-U.S. Holders&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">You should read carefully the discussion under &ldquo;United
States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement
and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information About the EURO STOXX 50<SUP>&reg;</SUP>
Index</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The EURO STOXX 50<SUP>&reg;</SUP> Index is composed of 50 component
stocks of market sector leaders from within the EURO STOXX Supersector indices, which represent the Eurozone portion of the STOXX Europe
600<SUP>&reg;</SUP> Supersector indices. The STOXX Europe 600<SUP>&reg;</SUP> Supersector indices contain the 600 largest stocks traded
on the major exchanges of certain European countries. The EURO STOXX 50<SUP>&reg;</SUP> Index is calculated and maintained by STOXX Limited.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
STOXX Benchmark Indices&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index from publicly available information and have not independently verified any information regarding the EURO STOXX 50<SUP>&reg;</SUP>
Index. This pricing supplement relates only to the securities and not to the EURO STOXX 50<SUP>&reg;</SUP> Index. We make no representation
as to the performance of the EURO STOXX 50<SUP>&reg;</SUP> Index over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the EURO STOXX 50<SUP>&reg;</SUP> Index is not involved in any way in this offering
and has no obligation relating to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40"><FONT STYLE="font-style: normal">Historical Information</FONT></P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the EURO STOXX 50<SUP>&reg;</SUP> Index on October
31, 2025 was 5,662.04.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of the EURO STOXX 50<SUP>&reg;</SUP>
Index for each day such value was available from January 2, 2015 to October 31, 2025. We obtained the closing values from Bloomberg L.P.,
without independent verification. You should not take historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: Black 1pt solid; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE40"><B>EURO STOXX 50<SUP>&reg;</SUP> Index &ndash; Historical Closing Values<BR>
January 2, 2015 to October 31, 2025</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><IMG SRC="image_004.gif" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">United States Federal Tax Considerations</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, a security
should be treated as a prepaid forward contract for U.S. federal income tax purposes. By purchasing a security, you agree (in the absence
of an administrative determination or judicial ruling to the contrary) to this treatment. There is uncertainty regarding this treatment,
and the IRS or a court might not agree with it. Moreover, our counsel&rsquo;s opinion is based on market conditions as of the date of
this preliminary pricing supplement and is subject to confirmation on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security. Such gain or loss should be long-term capital gain or loss if you held
the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders</B>. Subject to the discussions below and in &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us as of the date of this preliminary pricing supplement, our counsel
is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning
of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m).
However, the final determination regarding the treatment of the securities under Section 871(m) will be made as of the pricing date for
the securities, and it is possible that the securities will be subject to withholding tax under Section 871(m) based on the circumstances
as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Supplemental Plan of Distribution</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">CGMI, an affiliate of Citigroup
Global Markets Holdings Inc. and the underwriter of the sale of the securities, is acting as principal and will receive an underwriting
fee of up to $25.00 for each security sold in this offering. The actual underwriting fee will be equal to the selling concession provided
to selected dealers, as described in this paragraph. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI
a variable selling concession of up to $25.00 for each security they sell to accounts other than fee-based advisory accounts. For the
avoidance of doubt, any fees or selling concessions described in this pricing supplement will not be rebated if the securities are automatically
redeemed prior to maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">See &ldquo;Plan of Distribution;
Conflicts of Interest&rdquo; in the accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying
prospectus supplement and prospectus for additional information</FONT>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE40">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the securities is a function of the terms of
the securities and the inputs to CGMI&rsquo;s proprietary pricing models. As of the date of this preliminary pricing supplement, it is
uncertain what the estimated value of the securities will be on the pricing date because certain terms of the securities have not yet
been fixed and because it is uncertain what the values of the inputs to CGMI&rsquo;s proprietary pricing models will be on the pricing
date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time. See &ldquo;Summary Risk
Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Contact</P>

<P STYLE="color: #59AE40; font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="color: #59AE40">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#=A60*R 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MXHLHAACBB?\$4&.-( 8E3Q-""%$ 00^(QI^"IBU @(&\)3A0!^48%  !!&B
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M@ "\<'7T]T. 6'WPMBS,]&(W%6$6$P#W)@\4^)65:1B*,E3TEBF)Z(KJ94(
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MUW(N$=3[K 6JU28M3PG V@39*FK7*I4:JU^^ZP@!3 Z0#;8#FNM&G- -@/I
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M<*PR _)ZG=#11U"F+2)[$V(>/ZL%(!A"P-+!D0%0IP!Z2P#PK1=*JR9S0?C
M7/4'?:.^T)/JQMM$<T;X(P217IC:4<TP> &!T16-YMT$40'*<2O:$:2[(22P
M@G)$7[\-!C L2EWT)]'C(GYN&M :(,T)(0\BII1T$@"A++7!@1F?6W(;TX [
MG!#XL.QR[NQ:<F67@GC/'P [E?<K'_9"T $6<, *0  9_U OYUNI"5 H#3@
M#1#^_S$0YVX06X$M< _3</5@T,A8 !BX(CL $4=/!P$KUW^;-6P0@,Y& -%
M0@$(  QVJ&!0(8 %]R(T(;!0XD2*%2U>Q)A1XT:.'3U^!!E2Y$B2!N4!<8"
MR((  0:TA,DR)DR8+UO.6V APX$."DK^!!I4Z%"B12\RF !!@H0(#PY,D*@
M'P +"R1 -1@APL0&"1(H;-# H, +',9V,& 17P&C;=V^A1M7+M!^.H8@ &+"
M9DN9-/T&Z.MRP3\(!Y[.19Q8\>*@_H1HH. 30 $3$A<(6?"@ 4*%!;8"Z.=3
M08*("BT(Z0> @ 8%$@( N- A=?_%!J49W\:=6_=<)RE]_0O\MZ7-O3473.AP
M8$6YW<V=/R_:H(ED"Z\G,B @H</ A?'8 HBWU<*!!!HT$%"@ $*'!!T6P):@
MU'I% ]^AW\>?O[D\!/U7"@?,)0!C6B "(0Y 3S\%%U20@0<@R( T @[XC*(
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M616F6$9G=>C1+YD&Y6L":UFK.&2Y%'A)R &F>@Y?D5=V;E.\7.*8)FH'*/!
M(09@.6>C_)$@@YT.L "ZB74F.C$&Y.FCOPL&$-53F>?1P##W_XJF^B<&%L#:
M8VPKO;-JKXGRYN(%."YSIN.2 _IKM4N28 ?HP%T[[J"\1* 7,XNCEM '#I3
M6[G_QLB [;8[+.6N 4<\(P/Z0V""OP(=F\B>$J<\J@*:,,]>YX:NO//K;G1
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M>0A?K!4!OFC!EII%T#ZPX  0<.M=]=6 70H!L$ ="VJ6EZ#LD%4B Y# B3H
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M2R-$$R1+#.=D43W)MODQ@02HC%5"Q@'-SMO9$01L@KI$#!OLT42AKM_1@!6
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M!$C##%ZS%[ILA >"A4<,$-22 ?!UB.^(O)5.S^X >N@ (0)XJVA:4H(R"K"
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MKWBY';*3<!CAE]D$W4DVP77_.?@@5_'IQD ]G6'5$X09:KAA?P&ZMADO5SE
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MH=52P%3+PH^WWG5>S 2.RM0*L0C8<X]\*.S5RAHWY]'0:E5MRU4A&S$SMI1
MY[1; 3P55LW*C*; >B8"G$#8>05 K'6I)FDW&\B!1'!==8TM;C>(4">\[C,P
MS2UP[::GN!6F0(J]VP4V^I<'\".X:YTC.;DUA./>[;)I(4!CG:LL#SGS?=2]
MVS%SY5KM%DHA!,D&1CQ#G,"2ZP+9_0O7R.M)CT8D)@+A$ZUZ$3_Y\G=7$Y"
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M#>"NB00##&#W"=U((*!$2"!$\$/8 58!*B!)4.!#/"!+#:#]M-T _L4%7!\
M-%F/I:#,8& Z^8M>!4P4]8,'JB -IDD!'( 0_(,"7(X$-(#@R$39U* 0[DH"
M3( &!/\0^'1 "5U !RR !HS@$$9AAK#@ D" /R0- *#. Y!.!%R  4IA(^W4
M0/B,%PX$'SP ; $ D V$&))$ (0?092#!;'AO1"-^('$ JSA0 3 ' K$ M2A
MD-UA2.C@'O8A /PAC2B U4G  <@9/UP C!%>ZIQ@ VA QLR>'SY &0J$ 9S>
M&%;='D*AL1DB(MIA^WF$SQ@B&8;&'W:'(JY$ Z >T51>U1A 'RKB*4H$'QY8
M/UP <V%/'_9# .1B1.R=/>U==S2 (9Z829#80.##!5! : 0-(%:8V6 /_.'&
M!!Q .6"/WFB,4/B#!!10 VU/$VA XN!# BA71UC "N!?\&3_&/Y]1146P!,&
M7_KAWCA* ./((]L8'__L'SZJQ#;RC07LX\58CLB-Q>\91 "80  <0 ER#ML
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MR <3%IGNE>9 -&*,+N;. - $^&K7I71)VFK2;.AJ5_=!@&7EGF8#5$PW;RB
M$<!HCXZWZ8, C;;-]"!FC\[ AN4VVJ]V'T"! =! @&62EJ9/K2J[KF8C@N58
MK.H"8 Y8NC=96_=?H[9K)\@!]([&_'>9 (X_5$P'['=K*V46ZF58+D &+, V
M-I<0N%@&"$2$-?(!K(!I?D5IUB\W7H ^ $ %',!81-A_?P4%N#@ "$%!$[A>
M@^69*,!K@X]Z1^18S/_S 'AS":YH:\<#?UK8/!M?AF^C4"SS!4Q#L"VI!7SX
M-I9.!/!,V?C@ ;!X:\-X6+*V4(0XCA/X@Z-C-P_? :!>_<XH.HZV/ A!;K(-
M=F?A"HSY 7!>1&JX9<\H8QW #I3F#P' #K1V$X1E1)9@OQY >2>I-P^Y9/:Y
MG)<YCO]#?>K#7#KQ83;0]WC0T(AK!D#']_0D![CS 52/ 82-I8_Y0FA !F08
MEW2D4#  5@:?$&1 0N8?5&3 QC"6RGY/<RDAI9?Y_S8$$U;Q040DZ4@D0WC5
ML#\[4Q20V!XDF4.[M5\[MF>[MF\[MW>[MW\[N(>[N(\[N9>[N9\[NJ>[NJ\'
).[NW.TL$!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    00([ 8?O[^_____.SL[6UM;W]_=:K4+>WM[%Q<6UM;52K3J<G)SW[_?F
MYN:UO;U"K3&EI9RMI:U:K4J4C)2$C(RUUJW%UKV$A(1KM5I2I4+FSKU2M>89
MM>92YK49YK6$YA"]M1![K4(9$%I[>W,0*1ES:W.ESIR$Q7.,[]Z,I=Y[K7M2
MYN89YN:$K1"]YA!*A!E*4DK%YMZ$YD*]M4*]<^^]0MZ]0IP9YH1*6AD9YEI*
M$%K%K=X0"!ES8UI*,5)2A-Y2A)P9A-X9A)P9,5I[M6.EK7.]YD*<SHQ2WH2,
M[ZWO&8SO&3I2WEKO&6/O&1 ZWA 9K1 0WA!"M;4(M;7%K7.,Q83O:^;O$.;O
M:[7O$+7OSHSO6HSO6CKOSCI2K7OOE(SOE#KOSF/O6F/O6A#OSA#OE&/OE!"E
M8V.]8Q"$8Q#_[_?F[]Y26F.,A+V,$.^,$*V,8[V,$,Z,$(PZWC'%<Y09K3$0
MWC&<SMY2O2&E<Y1[SM[OG.;O0N;OG+7O0K5CM;4IM;4Z,3%*>TI*>VM[YH2]
MA+V]$.^]$*U[YF.]8[V]$,Z]$(SFQ>;%YH2].FM2.N^].BE2.JT9A&N$.FL9
M.N^$.BD9.JV,A.^,0N^,0JT9A"DIM81"I1F]$&M2$.^]$"E2$*T96FN$$&L9
M$.^$$"D9$*T96BDIM5JEA&.]8S&$8S%*$"E28^]28ZT98^\98ZW%8V.]A!"$
MA!!*,1#%YF.].DI2.LZ].@A2.HP9A$J$.DH9.LZ$.@@9.HR,8^^,0LZ,0HP9
MA @(M82]$$I2$,Z]$ A2$(P96DJ$$$H9$,Z$$ @9$(P96@@(M5I*$ A28\Y2
M8XP98\X98XSF[_=:[R'O]VOO]R'>YMZEYFN$:Y3O]ZV$Q:W%A&/%YL6]A#&$
MA#%[A%J,I:W%I:U:I1GFWN;%SN:]SJWFYMY"G#&$I9SW]__%O:VUO:7%K<7%
MSM;>WN;6SM:UI:7W]^_>[^^<I9RUI;5:I3KO]^]:G$)2G#KW__>]SL[.Q<6U
MQ<5CK4+6SL[___<(_P #"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES #"&A0T  $ P(--! @$$ #FC&#"AU*
MM*C1HTB34MPI0,%  PJ:XHP:-0"$?1" !C P 1Z$=1#"?A4[5BQ8LV3/AE5;
M=FW:MVCCNI7;MB[;NW#GZK6;ER]=O'_[ MX[V"]AP8@#*SZ\V+#CPI 3,Y[\
M6'+EQI$Q6\Y,F?/ESI+/9@0 SX  G (A )#)- " F^L$.LWI5!H :?;LW0:0
M>W=OV[]YZP8^7+COXL&3(U]^O#EQY\:?2X].73ETZ].Q5V>>G?OVZ]ZUB_\/
M3QZ\^>[GOZ-?K[[]^/3OV<=W7UY^??KP[\]/#@! .M48&4 "/S\-I( U6V7%
M$P!1T2/;:FFL(X%I PC@#S?O6 B#/Q9B*$ [%0J (8<;=I@AB *(^ Z)'%YX
M8H@C"E"BBQ_"N**,+7J(HHHLFEACBC'.J*.-/=*X8Y YO@CDC4(JR2../A[)
M9)(_/MEDE4A&22241FYYI91%#KEDF$YFV>687(II)95@IEGFE%JB^:67;-(9
MYYIWFJFFGF^2B26<9^(9*)]_^MEFB=Q 8$^ LTF@AD /C!/  #\M" $W0"FP
M6CKT3 !#BJ"&*NJHI)9JZJFHIJKJJJRVZNJKL,;_*NNLM-9JZZVXYJKKKKSB
M"N!%K\F6AD#Z\-3  ./$]DX#:4#@FK.TN=;?M-16:^VUV&:K[;;<=NOMM^"&
M*^ZXY)9K[KGHIJONNNRVZ^Z[Z:;1P&H8<?- 53 8D,:]#PA$CP*:!L /P*@%
MP(T":0 PCL(,+^QPP_T]+#'$$$_\<,48+YPQQAM/W#'%%G,<LL<C@_RQQB5?
MG#+#)[.\,LHMMPSSRC)''//+-M.,<\T\[^SSS4#K'/3'/0]]\:\8)2R0/_[T
M1!"]/4$=P#N: J#&M&IH;#76+-M\=7_R;*TUPU\#$/;58R]<]ME=DSTMVVEO
M#;;8U*K]-MW3VCTWVG7+_VTVWE[?S7?>?L/=]]J N[UWVWK_/7C@B\>-^..*
M.\YXX8DW;CCADU_>N>2">QXZZ)$?/KKII7-^NNJI0VXYZ:^C'COKL[N^N>V9
M;QWV.M)XU)]$4-EL ,O#NP/ \ M;<[S"5QL_3M8,*X]\\\P_+#WS #@/??++
M/Y]]]=%W3_WSUHO_/?GA3W_^]@!<[[WVY:L/?_K8S\^]_.#?7W_^[9MO?__X
M0Y_^WL<_]XV/?09<7_SV)T  ,A"!_BM@!!N8P/]54((!A& &%TA "DY0@P_D
MX %%J$#Z=1"$)R3A_ZJG/(==C1[#BDE3 K P>=00>L2SV?)RZ#*K:<QX.X09
M#O^!.+P>#K$_113B#Y&H0[4M,8A>>V(2H]@?(C;1AU5DHA&E>,4C0I%L7-QB
M%K_HQ#%.$8QF[&(8E9A&,7Z/C%A\XQG+*$<UMI&-=72C%?6H13SNT8]]I&(>
M 0E'+\XQCG\49"+1.$A%!E)Y8>N/\EC&NZ $#WLJNUH1-ZG%)%Y->7OTY/):
M&+'!>0^4G2SE*%UFRD_F493#(R4F58G*'<*R?RAK9?]"J<I8LO*7M>0D]GR9
M2V"^LI>X5&4Q@]E'329SEMAC9A"=*4OO+?.8PWRF-6F)3>\14YG<Y&4VJZE+
M:=Z2G,84IS>U6<YN4O.7UU3G.XNIL>&A#7I)C"0]I.;_DJ;\0Q[0^]KP;"A)
M+1(4AT4$(@XG"3.; 72)7ESH%1UZQ(AJC*$Z9-A#LVC1@O:0HA!]HD0_JM&*
MBO2B$RUI2,<XTH:JE*,G]:A+;[C2-[8THS2%*4M12M*<?J^C_>NIV4RZ4YGB
M=*@U52A/9XI4G=ITJ4?=Z$]C&E2F2M5X0,5HUWR*U2=JS9X:JV1,J'9%.BZ,
MDP2<9@ZY-XZP?9.>X.P>+MV:3+A"$WES764FX<E$MM*5E';=IEQ;^%>0Z;*>
MX6NK7OEZU\06=J]VQ2MA%QO8P4E688]EK& OJ]BWQG6SCJ7L9RT;6L]"$[1^
M%>UI29M:TPH6M7EU[6'[&MNZ_W[6EE ,&PR#<K"$A0^W-ILDRR8)1+9.JX@X
MM!OUL@C8H";3E'(KXO>:*UQ20E>@TS(>=:=E72-J<;H0JZ[;A/A=[8:7N^.%
MG'3-6[Z"VHV\.P1O>Y_KW?BR][?TA>]Z;2O>]ZHWN_Q%KW\5M]_MNA=O>BOP
M>0]\W?(&F,'U5?!\NZM? !LXO_]EKMPTQC<<KH.?+:%:.GP)W&]F\V%9"QM*
MS_A6M-GP:VI3\6##B<D7>TW&EXWF^C#K/;+A^+>GW'%;>QQCAN4XR-KC,8RM
M]F/NZ3C)0UZR&II<55="V<8^-C*0K5QC(C-9RTY&<I>E3&6&<MF:6"[R6;>\
MRS'?&/_,56XSFKT\93B;6<XNIG.9:3QG,MN9SWGV\YK#?.9 "\^!BM7:/H-"
MM801E(Y3O-YPXTC'KCJWAN1=,\6J^L7!>=%Y<BMNIUGV:<6)^HR>?B*HOW9J
M':9ZC*L>HZ8Y3&I5F_K0I*XUK&^MY5QSV-9Z:[6O^U/J8..:UK_>M;%[C6QB
M SO4QR:VKM\8ZS?.6MK)IC:OKXVW8D.;V=AVMK*_S6U/1UO7:I!&!2Z0 J$$
M+Z RWJ'RA O<R&94?03D6R2QNCQAXA:(H&[8/86,W>4!O(?6/"#V_IW%F0T<
MR@4O7L-S]G!,1ES;#G_@PCEY\(R?<.-,[#C%-=YCCD]<X"3_O[C(4?[QDH?\
MY"Y,>2I7'O.6JQSF%B?XS'&><)TS_'PCM_G.Y:I8+;JO/VE8]R92$$.8S#!G
M1D6L, <*LX-B&H<$13@6SRA+$T-ODM>#+LL.OL.O%]2>'[5UV9T<]K3O>NU!
M;7M#U8Y<MB]/['07-]CO[G9MPWWO:)_[V^L>=[X+WN^$!SR"=4CVQ)]]\6-O
MH]D=B/?!Z_WQE4?\Y2G?]\9O7NX3]3P69=Q"A+*,H ;@A@G.40"F6[)J=KLL
M1A>YSEGBD.5,K//%C@[-6LX,P%4-VYV]"O4Q,E3X<17UIH%X_#@3?_DR13XT
ME7^Q-S9_^+(NOO4C)GW!4K]KS.>^__.S#_W@C]_:V@\_9L__?:VI7['81W_Y
MKY_\L@*?_M.WO_'%'__VWY__]0<^CU-$=V8 %U  ")@ (M!T+]$4![9XA+=8
M4Y5]DV=6;L,^_4-<C\1$DS0\8&5QFF9>9D> N+5F&+A*(_AX<O6!7]4_*>A
M*XA%+:@\+RAI>,6"Q^6"^@.#-RB#.4B#.VB#6G:"OE2#)7AWU5>$07B$.,B!
M6"1I0FB"2:B#,!B%2-@U2EB%3.B#3FB$:'6%,_B$\K:%1,AID8=/M(5/%^
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MTVMXT29V13GR-LSS^6K-L?SH25G,,_^V\@MNZ!__&YN65[S2E>](?4G3 &$
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MFM(C#P.9AM@(71"CHI9- " @M-"D%)!T4J*<:D "-=(@60%_ H"@ 9+O4R"
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M1>DN*0"80*(JL#P%J"$ [TC4I'@G /]Z)&\HE9*  =KA#QCX0P ",*$ #""
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M9 [;$#G7&,'2^Q5>D4>?V;!90PU-T;CK [G,TPS .<#%H3(*+!8D\SR#5+Y
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M'WR@@C3H2,FX%P!('8M!(,SQ0C>I #E34/1PEU(#@!0@H)24N?($C0Q#"*&
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M< M!9?D4A^5 &Q$7R=/#&W.;QT0("A@8RM$0QZ \@_B.F+@ &+ &;I@5-3
M?_,WV!C+S)L3*W203<6.1KR(S5)7W<&/0(2ZVZ"2(B204BO) <3-0S76Z+RZ
MK8A."*1!TAM!:I2QKB5.NFD7?8$WL7 7 +3&50E,<Q,[?'Q4B1W5]?2Y##'2
M@_4XGL-/Q-':K?0-8KO8E)N+EGL^H:.1 /4+V!!9=?,+YC#4D8V3NIL?H%S
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MI)1XS[5UX4\H:J6D4M-9Y6%.##:9T%C!R=3>B0N^)-.QLS;YT%@ 4( !;A?
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MR8^E!(,*7+XQ0^#T<5K*'G5]MX_9=JWRQ%*XKJ_*S\[4U#+;*VZ"Z#?K[%9
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M041V.@9D&*<T[.$[AB=\QB=OKH,T-!( P /FT(-%*(!'&  \- !K*H  Z&<
M2(!VM.8$", ^J":#+JB#-BB#0NB#5H"$5NB#"@"$8NB#;FB%4BB$4NB#6FB%
M-B@_@&A++FB$<JB*JB8_C&B(HBB,-H"'KFB,TJB(VBB.WNB'GFB%:JB.ZFB.
M!FF'6B@_[/_#.J@+!S9 .]S&O,S#/NQ#D4+I:CC !4"I@V*HAO*#  B /^C
M:KP5/V2+ !3ID*ZHB3IHD1[I:?!& LS#F"ZH/O##-Z1 "CPID *HA0H !,B+
MV^#IBM[IBP)J2_HHAY[IC@KIAI9HAH*#=C"2 DQ  TS !)BF/ 2 /P H:T+
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M;,;69L;T9EOD"L=2;6YZK,A.[' Z;&@^D 'XPRN6(BLV0$54@ 3 9@2Y8D7
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MPC$1,2;+0B680%"!T&H9-W##7>)L2JP>NW92_4+-.+2GM65>GN7D4+!']D3
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M-  N."C@ ,,F$Q&M082H!B4  P!@LI0W3@U,=S!IJG2($T#-ESA]NH3Y4RB
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M7MEJ%H;_K'<9&X&IB?922=-*98 &[*,!$N#!J@CRJ@:D@2  4( ")B"0!BA
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M(@AH./3O1:*)J\8R7G I2RKB!AM##A/CLW+%5C8!9,H23&K"#K^""G1&+HR
M*@: E2 F : O!QND6QP@!8RB BI@ #3'7&;$?0R%@S11@C(R->+%B)"".0!@
M5W %2M#)([1L$U[I*U\BAR+S-7&J<1"+@RK3*V_KE\R$4\2K+5)"8B2C>HBF
M.8*S4'BH:"BDKO8& " I/R8@O=; *%41(:JNS22@_D:D3Z#+=TI [O0R#?AA
M,C^"):3!C<3F N:E)4Q2()="6+""?<#DI+(EP@Q R)((!LI!<1B$>WZD#].
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MU]8!B!Z\ ! \:  @VO8=5SUP@P:H%3P:P(\ 8%  >D.'=[2VJWE8D!_[J(
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MA3GSXQB_,U7NF-G;94*[B75VS>U)$0;=LJ9U<,+';N709VLHG@ /+ Q4]!A
MT"@.SSLX2)JL,:])(5\>P^*#E<9)[EK<2,<_"Q"!"T0@0 +;G -,D$(J0'=
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M@,H@0X3HC>[HCP[IAFX/0GT>_"!'+_ "X!JN=,YC_-   T /XP /%_3_  )
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M-R4+C<"@G)9Z#H)**\%)EGR!'\E!0\M:-D\;+3<RHK?C*L%H/3Y* UC#P "
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MWW'#"$#CR(P [&GTIT!BQ)80!5*$&'-@08@V61X4Z#"GFHD,*8[K^5*HSYE
M<;(\&C3BS)8U?0J4R7!IP:<]*0YDJ/4E4J<+G[K<VG!@TX-<J1(-^Q. PXA#
M(RYMN_2@4JAKZ1*\RI0MV;4"QWWUF5?K4Z!I;_J4V[-JS[9*&Z>EZE/J7+N3
MQZJ]:9CO7KQQ:2[D^GBPY*-BH4;_7GSY<E6U1]_6-=L7+T3%, <CACAP74F/
MOG\' ) &>$<8"M)TE2I8Z^K<71/2! "=<%:!TPLR5]A:L&ZLVX]BU=W2*8#
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M4F %6N %8F &:N &<F '8F#;>6 (BN (DF )FB $PH/[3-%*9(0"C,.@P4,
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M>F8@F(\@F5^@F8=YFC,@FJLY"1Y,FW/@Q#EB"UL4//CWR,"#&:+AE>.@#AI
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MM4X=6A0PW[U=6:HA&]5H60!O,3[]*G2D40"&[<;L25-RS)$=5R:U7)4MY9A
M=?;\2';BYIOC4"^FJK;JU\E(HW[6"3DE@'4*%_;V_1MX<.'<%*21I[%CZ;NY
M3ZHQ[7FJX\A<H3O/?;SGVYK;Z4H=J?,I]LQ&Y?7L'+>F]7'6RD94:KU\SIWH
MS>9^K]8Z2N1?W>6OJUH_F[Z2J">_NE.*0+2&>BFA^/)+\+W8A#I,-@?K&M O
MM3K*KR.7GL/0M=P*J\JZD4+Z$+\/Q;.JJ@^_FRRCN+ "L4/F5DOL)O DPO!!
M&(_ZS*_4?-P/I8^<4R^\!,6+#P!Z[!$.RBBE_USH'8<N_! HMOSZBCH!57ON
M)*"6>RS$S_;:CK$;"]S0*1JAFC&RF]AJ,Z:A)%(NP SSNB@D,3G3:D3W!G3,
M.8X4A$LZMXJ$"D@M8Y13MAB%3(\D\.PSS[5"C8(SJ2Q!Y$G(SD $\='06,/1
M(J9RG$PJO "L$S;"%)0ML_U@8A7($!UU[%&<7BU3Q#U7XY7781]J@+<IE5V6
M( .*B]#564V=];)9?RTT._M&ZM%'N[J-5DBL5$6)R1KSO @O3"<E;3LM9ZR/
M3'*=@O#&LVYB$C:7./1*,OA<O'11N4A:46"!(_OW)NMTZFQ<>CLJKS&'-X4N
M*P W-%C;W/(#U:;ZU/_36,5LSS778JH U$Y'8-GS<<<7F703I;WB._/7@5.T
MLUL(DF66YR@%4, >02,[&2<_!TT/TWC?Q4E4=^4+&+U3LQ(3+U_Y*ADLJ=N"
MN=&,)T[SU:?RC5FR%Q.;B.&!O=[6O3:Q!M5&L/P2JV)K6\694;2G2CG$J6:,
M,=6 ?]5R[JE@>[JIP(?FRS)XA9+L3*>CLR^L3J4*,4U1L3Z:TP$-9=IP5'7;
MN>?2?W-6&A]KWM;OI-Y]SDL%/ZZ[8#;?A$J\$N?S4=7.(;SVT7V9S&_ANL[,
M#4@ Y6ZP6K7VRL\_R-'M%L!RU_;J,*QFM-=LDNU&,%/6>@4*^AMU?UGYK,K_
MGM6[B;_RCRWVD R_=1"UVY@[2']W_S;PE?/]6]>SSKY6I3FJ$!!3ERE03YQD
M.@?^YF=I4!]=;.,M+FT'4MXZ6%1*=J;G]&<CO<**1K;VI^\A;$89$E*:DJ:@
MBW'O-?#2C-7HMJI%M<UR\2K-I+"6H#I1AVPSC!=(J)478AFH7HP[$:M*!L(:
MQ2YK\4EA]RX(E8:QBE9O\XN89,6?RRWP1J!SWY^2!B!'&7%YKA,62PYSJGU9
M!UD/E"-!&F(/U;WF1[AR(;^6])POF8QZ>T+8Q[B5H/Y R"98>]C^E":L\ @L
MD?PR6K^:-YYNQ<8F\8D5JPB),"22:5K:(96TD'<Y_^K\L4<$=)^_^/(Q#X9Q
M7&3$8IXVIYKD8,PUMOR>]727KLNYA"MX$5*/& G)1H+/>C;#I2*'-#WB/41G
M<YRC/Q3P#T_)!FXP5*';II:4E2UQB)0A&AA!F14-24:-TMM1&4\H-MYYDUKA
M"M:\L BD_IUMB95SB7+@M3ZKA3,EX+Q:JS[WQY9=*9U/$^598 <RA:;S5($!
MYIA\\J"0$$UY/7$,B613,R%^J*,7NM6M8&,I&)H)GD<[:*WT>$P@"2J@<HNC
M-!\(@V=1<8/'?"5LY.F?1T%,3U5C'0A')2]^^<2  E(8CICI11E.[U_XDJ0E
M[\FW<"9H.CE,&6X^J3T?0?^,>93[I%%FIRH#JL9?3V&E^_;W1K5H]%Y^A(Y8
M/*G+E8&K*DP:#(_"6D[)Z*2J%S2A>PA8E(]QU8=XK-3E7*I.E4+S231U(#5K
MTQAC,5- 4KO83QC5&D3R<$&JT0Y=S"7$&L62L?RT8DP;JS+[ -0R@:O3!5%4
MQ+<&ZRZ.H=I8CCE8QG7K/*"%&D0MN;@R639SQK)7;>M2GT!1!ETA\<^(CGD4
M/1ZF-2[YVU/UEKS?X@B\QOLDGK)XM[^V:C^9K5RFO!5;DNQ&LI.M9DG72,H#
M^M)2Z\D:XKIU4D&"+Z2H]=I>E%HI5P9R?<&U43+_AN!#VD4U,]-@'L\DRKW2
MK[K_#3;6X=BF1K"N+UI#!-@H!<Q,C9"WP0UB$+^\2D C$3:Q&;3.N%2E0 37
MUFE=N9PVSZI8M%:2=?C=KS;;U"1IQ-=TSHIIH IJ-PV[<TS=&1N)GF-97=JM
M::!1XZD2=R.#\L5&(^J<Y(2FV*/I%%!*S-]W7W51JA@0O*<REZ=2>*'7>D]3
M1$Q:U2)J'YK)ITZE]1A4]\@G@'G6O.N<%&</Q5;'#32("?W(71<-Y5H*JU26
MXS*8P589QZSC($CNV<\"T!PL(?C2,W:-,)VWXD5*[\\#XQ8>$4A* 6EY3(0R
M2N\ ["8X3PN\'5Y=$778TKV,\%^J9&>5"S3 F['G.&K\_U.<7C?0S.9IAE T
MT:U?/3LOAE3+MM-348"23+8 :+HC[MQ0O$>KX67KT60JF50#AK^"::>A\K%(
M T7-,R6KL*N%EEH+X7U4,,_.;"\]FTG1:,8)BM&[>%%.EZTVHG'Q2'^_U2RD
M.W@EL0FW+0C[5Y?2W+=;KN8P)%0)GU\#M[2(%486N=738(+H'XZ2,BY&H\+;
MHIHY65FQ%08DCD359Q:QG(+/U,IRW9S.SFW0AQ3ZT*3.1I*9]GM9$5R1AKNH
MO,+X\F'/U.4?QSB9^ZT).B)'<&>V+:Q75F28@D*[EE?V[3!)A=RX(I+:,]CV
M'/Z85=KTZ'EKI5'FZ79ZM,NJ6/^G[;_]$LA!G$TE)H=TV_>!"6"=<?91K]BO
M3[UV.XXQ-4*S1]S[ KKR@2R9<"\&*54G=7<@BB;6@_,S!0AD( WQLRG7;-QX
MQ<T]6KKG.LT\(RT9,-9FPQ"?%VTH];9(8X*-Z<4#M9PT9:C)[5MT(%=6ZQ U
MU>>-7MQGM8)"/)YFU:\E+,K3*$K"ZP5S@ 8M2+DL&HJ)K+2?L\E9YL0PEK/E
M?M!+J 9J>UI*E$SH5U"D/C9-;LQI:S"D*."+]GX# !Q" "" ('[F'U@&@S0B
M\@J-3:0J3E;*BZI&/+1H[L)*Y^*%UZ(C:9B$;[!"8@JKV( /?%!IOUX&@UXD
M>I*/<LS_#]Q8YTPH!"ND"'QBK2M&;V(TC\H"2.]N*(!6*J=,1-X""%O69_ML
MQZ<"2,<B!=SV!:;NB-[(9*G<"K?"K]: ;K%TYXYHJTDB:P)[0P :8" <8B"<
M)0"@0@_WD _[,"DDR \#41 'D1 +L1 !T0_3('7\<!$-T1 1T1$C41(GD1+W
M$!(I\1(M,1 5L1(/41 SL1-#413YL!$[D1,3L13YT(XV\2'LX>KBD"#V 0,#
M0 *>I )Y0 %R41=W<0)VT1=SL1=_D1>%T1>#D1@5P!B),1F%<1F9\1B1\1FA
M\1F;\1<E(!JI<1BG,1JM41N?D1N/$1NCT1>_41FOT1R[$1S/__$8T8$<G3$=
MGY$=U;$<T7$>W_$8VU$<W=$>E?$!Z%$?)R#48#$#Z3  YJ%9]"$0Z<%(U <
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MK54"D',-[O !#& "_&$AUN @K.%P.74A2/\V#R'@ M-61NDP#2#@+"4V824
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MO"60G^N;N]N[ =:!N^<PO,<[O,_;O-V[30?<N(=YP!-4O[\2.1=<6B'6OQN
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M9Q2 YB$6$-(S[_UA[\=^=>\0$ JV 6;OU'>XK0& \)OE[5G7X ="/W&/=E\
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M!>VSL03SS90&."'?[.]:]/ PL07Q$J3=P SQ;,'!VJ&TQ@L-Y]P9 #WWRQH
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JM% ;M5([M51;M59[M5B;M5J[M5S;M5[[M6 ;MF([MF1;MF9[MK(:$  [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
